KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Shares Outstanding (Weighted Average) (2016 - 2026)

Biocryst Pharmaceuticals filings provide 16 years of Shares Outstanding (Weighted Average) readings, the most recent being $209.9 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 1.55% to $209.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $209.9 million, a 1.55% increase, with the full-year FY2025 number at $209.9 million, up 1.55% from a year prior.
  • Shares Outstanding (Weighted Average) hit $209.9 million in Q4 2025 for Biocryst Pharmaceuticals, roughly flat from $210.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $210.2 million in Q3 2025 to a low of $177.7 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $189.2 million (2023), compared with a mean of $194.0 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 15.23% in 2021 and later increased 1.35% in 2025.
  • Biocryst Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $179.1 million in 2021, then rose by 3.79% to $185.9 million in 2022, then grew by 3.38% to $192.2 million in 2023, then rose by 7.54% to $206.7 million in 2024, then grew by 1.55% to $209.9 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $209.9 million (Q4 2025), $210.2 million (Q3 2025), and $209.2 million (Q2 2025) per Business Quant data.